Of those tested for CHEK2 (122), for Lynch (69), or for RAD51C/D (15) genetic mutations, none was found. Somatic test results were available for 280 men whose cancer had spread elsewhere.

PROTECTOR is a multicentre, national prospective cohort surgical study for premenopausal women who are at increased risk of developing ovarian cancer either because ...